Through analysis of SAA expression in Oncomine datasets profiles from ovarian cancer patients, we found that it is overexpression in ovarian cancer samples (109 cases) compared with adjacent normal tissue samples (37 cases) (P = 0.008, Wilcoxon-Signed rank test) (Fig. 1a). Here, SAA1 is linked to ovarian carcinoma.